ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres

Brain Pathology

Volumn 25, Issue 6, 2015, Pages 724-732

  Kahlert, Ulf D ^a,b   Suwala, Abigail K ^b   Raabe, Eric H ^a   Siebzehnrubl, Florian A ^c   Suarez, Maria J ^a   Orr, Brent A ^e   Bar, Eli E ^d   Maciaczyk, Jaroslaw ^b   Eberhart, Charles G ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Institute of Pathology   (Germany)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

EMT; glioma; hypoxia; neural stem cell; ZEB1

Indexed keywords

DIGOXIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PROTEIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR ZEB1; HIF1A PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN;

ADULT; ARTICLE; ASTROCYTOMA; BRAIN HYPOXIA; BRAIN VENTRICLE; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CHILDHOOD CANCER; CONTROLLED STUDY; DRUG TARGETING; EPENDYMOMA; FETUS; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; NEURAL STEM CELL; NEUROPATHOLOGY; OLIGODENDROGLIOMA; PILOCYTIC ASTROCYTOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR INVASION; ANTAGONISTS AND INHIBITORS; BRAIN TUMOR; CANCER GRADING; CELL CULTURE TECHNIQUE; CELL HYPOXIA; CELL MOTION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TISSUE MICROARRAY; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL CULTURE TECHNIQUES; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HOMEODOMAIN PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; NEOPLASM GRADING; NEURAL STEM CELLS; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; ZINC FINGER E-BOX-BINDING HOMEOBOX 1;

EID: 84946221385     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12240     Document Type: Article

References (62)

1. Arima Y, Hayashi H, Sasaki M, Hosonaga M, Goto TM, Chiyoda T, et al (2012) Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer. J Biol Chem 287: 7896-7906.
2. Bar EE, (2011) Glioblastoma, cancer stem cells and hypoxia. Brain Pathol 21: 119-129.
3. Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG, (2010) Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 177: 1491-1502.
4. Brabletz T, (2012) To differentiate or not-routes towards metastasis. Nat Rev Cancer 12: 425-436.
5. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T, (2005) Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749.
6. Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH, et al (2004) Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64: 920-927.
7. Chaffer CL, Marjanovic ND, Lee T, Bell G, Kleer CG, Reinhardt F, et al (2013) Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154: 61-74.
8. Chang C-J, Chao C-H, Xia W, Yang J-Y, Xiong Y, Li CW, et al (2011) p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 13: 317-323.
9. Chen L, Han L, Zhang K, Shi Z, Zhang J, Zhang A, et al (2012) VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling. Neuro-Oncol 14: 1026-1036.
10. Darling DS, Stearman RP, Qi Y, Qiu MS, Feller JP, (2003) Expression of Zfhep/deltaEF1 protein in palate, neural progenitors, and differentiated neurons. Gene Expr Patterns 3: 709-717.
11. Elias MC, Tozer KR, Silber JR, Mikheeva S, Deng M, Morrison RS, et al (2005) TWIST is expressed in human gliomas and promotes invasion. Neoplasia 7: 824-837.
12. Esencay M, Sarfraz Y, Zagzag D, (2013) CXCR7 is induced by hypoxia and mediates glioma cell migration towards SDF-1α. BMC Cancer 13: 347.
13. Fujiwara S, Nakagawa K, Harada H, Nagato S, Furukawa K, Teraoka M, et al (2007) Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol 30: 793-802.
14. Gessler F, Voss V, Dützmann S, Seifert V, Gerlach R, Kögel D, (2010) Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells. Neuroscience 165: 1312-1322.
15. Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, et al (2011) An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell 22: 1686-1698.
16. Han S-P, Kim J-H, Han M-E, Sim H-E, Kim K-S, Yoon S, et al (2011) Snai1 is involved in the proliferation and migration of glioblastoma cells. Cell Mol Neurobiol 31: 489-496.
17. Hatzikirou H, Basanta D, Simon M, Schaller K, Deutsch A, (2012) "Go or grow": the key to the emergence of invasion in tumour progression? Math Med Biol 29: 49-65.
18. Hegi ME, Diserens A-C, Gorlia T, Hamou M-F, de Tribolet N, Weller M, et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352: 997-1003.
19. Hill L, Browne G, Tulchinsky E, (2013) ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int J Cancer 132: 745-754.
20. Höring E, Harter PN, Seznec J, Schittenhelm J, Bühring H-J, Bhattacharyya S, et al (2012) The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase e and mediated by metabolic stress. Acta Neuropathol (Berl) 124: 83-97.
21. Jensen RL, (2009) Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 92: 317-335.
22. Kahlert UD, Maciaczyk D, Dai F, Claus R, Firat E, Doostkam S, et al (2012) Resistance to hypoxia-induced, BNIP3-mediated cell death contributes to an increase in a CD133-positive cell population in human glioblastomas in vitro. J Neuropathol Exp Neurol 71: 1086-1099.
23. Kahlert UD, Maciaczyk D, Doostkam S, Orr BA, Simons B, Bogiel T, et al (2012) Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. Cancer Lett 325: 42-53.
24. Kahlert UD, Nikkhah G, Maciaczyk J, (2013) Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Lett 331: 131-138.
25. Kalluri R, Weinberg RA, (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
26. Keith B, Simon MC, (2007) Hypoxia-inducible factors, stem cells, and cancer. Cell 129: 465-472.
27. Korpal M, Lee ES, Hu G, Kang Y, (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283: 14910-14914.
28. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, et al (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63: 1138-1143.
29. Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, et al (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15: 501-513.
30. Lopez WOC, Nikkhah G, Kahlert UD, Maciaczyk D, Bogiel T, Moellers S, et al (2013) Clinical neurotransplantation protocol for Huntington's and Parkinson's disease. Restor Neurol Neurosci 31: 579-595.
31. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (Berl) 114: 97-109.
32. Luo D, Wang J, Li J, Post M, (2011) Mouse snail is a target gene for HIF. Mol Cancer Res 9: 234-245.
33. Mahabir R, Tanino M, Elmansuri A, Wang L, Kimura T, Kimura T, et al (2014) Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma. Neuro-Oncol 16: 671-685.
34. Mao X, Hütt-Cabezas M, Orr BA, Weingart M, Taylor I, Rajan AK, et al (2013) LIN28a facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program. Oncotarget 4: 1050-1064.
35. Méndez O, Zavadil J, Esencay M, Lukyanov Y, Santovasi D, Wang SC, et al (2010) Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Mol Cancer 9: 133.
36. Mikheeva SA, Mikheev AM, Petit A, Beyer R, Oxford RG, Khorasani L, et al (2010) TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer 9: 194.
37. Mohyeldin A, Garzõn-Muvdi T, Quiñones-Hinojosa A, (2010) Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 7: 150-161.
38. Nagaishi M, Paulus W, Brokinkel B, Vital A, Tanaka Y, Nakazato Y, et al (2012) Transcriptional factors for epithelial-mesenchymal transition are associated with mesenchymal differentiation in gliosarcoma. Brain Pathol 22: 670-676.
39. Pàez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Viñals F, et al (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15: 220-231.
40. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM, (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3: 347-361.
41. Proescholdt MA, Merrill MJ, Stoerr E-M, Lohmeier A, Pohl F, Brawanski A, (2012) Function of carbonic anhydrase IX in glioblastoma multiforme. Neuro-Oncol 14: 1357-1366.
42. Sánchez-Tillõ E, de Barrios O, Siles L, Cuatrecasas M, Castells A, Postigo A, (2011) β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci U S A 108: 19204-19209.
43. Sánchez-Tillõ E, Fanlo L, Siles L, Montes-Moreno S, Moros A, Chiva-Blanch G, et al (2014) The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma. Cell Death Differ 21: 247-257.
44. Ali MA, Reis A, Ding LH, Story MD, Habib AA, Chattopadhyay A, Saha D, (2009) SNS-032 prevents hypoxia-mediated glioblastoma cell invasion by inhibiting hypoxia inducible factor-1α expression. Int J Oncol 34: 1051-1060.
45. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM, (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
46. Savary K, Caglayan D, Caja L, Tzavlaki K, Bin Nayeem S, Bergström T, et al (2013) Snail depletes the tumorigenic potential of glioblastoma. Oncogene 32: 5409-5420.
47. Shen SH, Kwan AL, Chen YY, Wang ZX, (2013) Effect of silencing HIF-1α on proliferation, invasion and migration of glioblastoma U87 cells. Neurol Sci 34: 365-371.
48. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, et al (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138: 592-603.
49. Siebzehnrubl FA, Silver DJ, Tugertimur B, Deleyrolle LP, Siebzehnrubl D, Sarkisian MR, et al (2013) The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med 5: 1196-1212.
50. Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Hlubek F, et al (2008) The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68: 537-544.
51. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
52. Szalad A, Katakowski M, Zheng X, Jiang F, Chopp M, (2009) Transcription factor Sp1 induces ADAM17 and contributes to tumor cell invasiveness under hypoxia. J Exp Clin Cancer Res 28: 129.
53. Tabatabai G, Stupp R, van den Bent MJ, Hegi ME, Tonn JC, Wick W, Weller M, (2010) Molecular diagnostics of gliomas: the clinical perspective. Acta Neuropathol (Berl) 120: 585-592.
54. Takeshita I, Takaki T, Kuramitsu M, Nagasaka S, Machi T, Ogawa H, et al (1987) Characteristics of an established human glioma cell line, KNS-42. Neurol Med Chir (Tokyo) 27: 581-587.
55. Thiery JP, Acloque H, Huang RYJ, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
56. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, et al (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting micrornas. Nat Cell Biol 11: 1487-1495.
57. Yang M-H, Wu M-Z, Chiou S-H, Chen P-M, Chang S-Y, Liu CJ, et al (2008) Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10: 295-305.
58. Yen G, Croci A, Dowling A, Zhang S, Zoeller RT, Darling DS, (2001) Developmental and functional evidence of a role for Zfhep in neural cell development. Brain Res Mol Brain Res 96: 59-67.
59. Zagzag D, Lukyanov Y, Lan L, Ali MA, Esencay M, Mendez O, et al (2006) Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 86: 1221-1232.
60. Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, et al (2008) Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci U S A 105: 19579-19586.
61. Zheng X, Jiang F, Katakowski M, Kalkanis SN, Hong X, Zhang X, et al (2007) Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness. Cancer Sci 98: 674-684.
62. Zhou X, Liu Z, Shi Q, Jiao J, Bian W, Song X, et al (2013) Geranylgeranyltransferase I regulates HIF-1α promoting glioblastoma cell migration and invasion. J Neurooncol 112: 365-374.